{"id":1327,"date":"2025-05-08T09:58:13","date_gmt":"2025-05-08T07:58:13","guid":{"rendered":"https:\/\/simgbm.it\/special-issues\/new-drugs-and-novel-strategies-against-nontuberculous-mycobacteria-2-0\/"},"modified":"2025-05-27T12:02:45","modified_gmt":"2025-05-27T10:02:45","slug":"new-drugs-and-novel-strategies-against-nontuberculous-mycobacteria-2-0","status":"publish","type":"special-issues","link":"https:\/\/www.simgbm.it\/en\/special-issues\/new-drugs-and-novel-strategies-against-nontuberculous-mycobacteria-2-0\/","title":{"rendered":"New Drugs and Novel Strategies against Nontuberculous Mycobacteria 2.0"},"excerpt":{"rendered":"<p>Nontuberculous mycobacteria (NTM) are opportunistic pathogens, causing pulmonary diseases in immunocompromized patients (e.g., cystic fibrosis). Possible contributors that study new drugs and novel strategies against NTM are welcome. <\/p>\n","protected":false},"template":"","class_list":["post-1327","special-issues","type-special-issues","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.simgbm.it\/en\/wp-json\/wp\/v2\/special-issues\/1327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.simgbm.it\/en\/wp-json\/wp\/v2\/special-issues"}],"about":[{"href":"https:\/\/www.simgbm.it\/en\/wp-json\/wp\/v2\/types\/special-issues"}],"wp:attachment":[{"href":"https:\/\/www.simgbm.it\/en\/wp-json\/wp\/v2\/media?parent=1327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}